Bufotalidin
CAS: 465-90-7
Ref. 3D-AAA46590
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Product Information
- (3Beta,5Beta)-3,5,14-Trihydroxy-19-Oxobufa-20,22-Dienolide
- (3Beta,5Beta,8Xi,9Xi)-3,5,14-Trihydroxy-19-Oxobufa-20,22-Dienolide
- (3β,5β)-3,5,14-Trihydroxy-19-oxobufa-20,22-dienolide
- 19-Oxo-3-beta,5,14-trihydroxy-5-beta-bufa-20,22-dienolide
- 5-beta-Bufa-20,22-dienolide, 3-beta,5,14-trihydroxy-19-oxo-
- 5β-Bufa-20,22-dienolide, 3β,5,14-trihydroxy-19-oxo-
- Brn 0056259
- Bufa-20,22-dienolide, 3,5,14-trihydroxy-19-oxo-, (3beta,5beta)-
- Gellebrigenin
- Hellebrigenin
- See more synonyms
- Nsc 89594
Bufotalidin is a caffeic acid derivative that has been shown to have inhibitory properties on the heart and locomotor activity. Bufotalidin was shown to decrease the cardiac contractility of isolated rat hearts by inhibiting calcium influx. It also inhibits basic protein kinase C (PKC) in HL-60 cells, which may be due to its ability to inhibit PKC translocation from the cytosol to the membrane. Bufotalidin also has an inhibitory effect on autophagy, which is a process that breaks down cellular components. The molecular mechanisms underlying these effects are not yet understood.
Chemical properties
Technical inquiry about: 3D-AAA46590 Bufotalidin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.